Pharma firm opens $136m UAE plant
Julphar's Ras Al Khaimah facility to produce 45m insulin vials a year
Gulf Pharmaceutical Industries, Julphar, has opened its new $136m (AED: 500m) plant in Ras Al Khaimah which will be used for making and distributing insulin.
It will be capablee of producing 1,500kg of insulin a year - or around 45m vials. Capacity will be scaled up based on demand, the company said.
Julphar first began producing insulin eight years ago from crystals imported from Europe, but now produces the crystals in-house.
The company said that the market for insulin is likely to increase over the next few years.
"Some 20 per cent of the Gulf's population now has diabetes with the number likely to double by 2030 if action is not taken to contain the disease," it said.